Aurora Cannabis Inc
Gauging the Bullish-Bearish Sentiment on Aphria
The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.
Do CGC, ACB, TLRY, and APHA Look Cheap?
With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.
Cronos Group Invests in the Future
Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.
ACB, APHA, CTST, and HEXO Fall on March 20
The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.
Aurora Cannabis: Analysts’ Projections
Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.
Checking On Canopy Growth and Its Peers
Canopy Growth is one of the strongest players in the cannabis industry with a market cap of ~24 billion Canadian dollars.
Does Cronos Group Look Expensive Compared to Its Peers?
Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.
Marijuana Movement: Why Do Celebrities Support It?
Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.
Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’
Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.
What Does President Trump Think about Marijuana?
President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”
Canaccord Genuity Raises Price Target for Canopy Growth
On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Why Vaping May Not Be a Gold Mine for Cannabis Players
In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.
Aurora Cannabis’s Revenue: Here’s What Analysts Expect
Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.
Aurora Cannabis’s Price Target Cut by 30%
Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.
Marijuana Policy: Can California Shape It for the US?
Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.
Marijuana to Treat New Conditions in Minnesota
In August 2020, chronic pain and age-related macular degeneration would be eligible for treatment under Minnesota’s medical marijuana program.
Cannabis Legalization: Four Governors Met in New York
The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.
Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.
Canopy Growth Receives Target Price Upgrades
Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.
Cannabis in Mexico: Legalization Bill Is Ready for Voting!
Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.
Mexico Will Attempt to Legalize Marijuana in 2020
Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.
Tilray Invests in ROSE LifeScience
On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.
Revisiting Valuation Multiples for Cannabis Companies
Recreational cannabis is close to being legalized in Canada, and producers are running at full bore to capture a piece of the market.
HEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.
Cannabis Sector Closes Positively in the Week Ended April 13
Last week (ended April 13), overall market sentiment was positive, with the S&P 500 rising 2% and the TSX 30 gaining 44 basis points.
Canopy Growth Stock Rises, Oppenheimer Initiates Coverage
Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.
What Do Analysts Recommend for Canopy Growth?
On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release.
Can Canopy Beat Q2 Estimates and Boost the Sector?
This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.
Cronos Group Joins Altria to Bet on Cannabidiol Market
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.
Marijuana Vape Products Expected in Alberta Stores
AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.
Why Canopy Growth Isn’t Happy with Apple
Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.
Aurora Cannabis: What to Expect from Its Q4 Results
Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.
South Dakota Plans for Marijuana Legalization amid COVID-19
Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.
Marijuana Legalization Continues: Wisconsin Steps Up!
Marijuana laws are pretty strict in Wisconsin. Although cannabis is spreading its roots across US states, it’s still illegal at the federal level. President Trump and his administration want states to decide. Florida, New York, and Minnesota are all gearing up to legalize adult-use cannabis. Now, Wisconsin is pushing to legalize medical marijuana. Let’s see […]
Is Aphria a Good Cannabis Pick for 2020?
Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.
Will MedMen Deliver Any Good News in Its Q2 Earnings?
MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.
Cannabis 2.0: Aphria Gets Ready for Edibles Market
Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.
Big News: Cannabis Edibles in Alberta Stores
Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.
Elizabeth Warren Unveils Plan for Marijuana Legalization
According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.
Medical Marijuana Is Booming in OK, Struggles in OH
Medical marijuana is a hit in Ohio since it allowed it in 2016. Recreational cannabis is still not allowed. Notably, data has shown that Ohio’s medical cannabis industry is booming since it started in 2019. However, the medical cannabis industry is facing some setbacks as well. So, let’s take a look at it. Ohio and […]
Marijuana Industry: Opportunities in California amid COVID-19
Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.
Medical Cannabis in Brazil Is Coming
According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
How Cannabis Stocks Fared Last Week
Tilray was the top performer in the cannabis sector last week with a rise of 49% as a result of better-than-expected second-quarter earnings and guidance.
Marijuana: Will Trump Have an Edge over Biden?
With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.
Aurora Cannabis: Analysts’ Target Price after Its Earnings
Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.
CBD: Japan Welcomes NBEV, Stock Pops
Today, New Age Beverages Corporation (NBEV) announced that it would launch its CBD (cannabidiol) based products. Share prices jumped by 14.96% to $3.20.
Marijuana Legalization: O’Rourke Blazes His 2020 Campaign
Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.
Marijuana Legalization: South Dakota Does What Trump Said!
Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.
Aphria: Why Jefferies Recommends a ‘Buy’
Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.
Canopy Gets Estimates Revised by Analysts for 2020
Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.
Tilray: Are Analysts Optimistic about Its Stock?
After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.
Cannabis Roundup: HEXO, WEED, ACB, and CTST
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.
Cannabis in Kansas: Residents Are Taking Action
Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it’s illegal in Kansas. Even having a small amount is considered a crime.
Why Aurora Cannabis Stock and Peers Are Struggling
Aurora Cannabis (ACB) had a hard time this year. ACB stock had been investors’ favorite in 2018. The stock started off 2019 on a good note
Why Alcaliber Makes Sense for Canopy Growth
On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.
Canopy Growth: Why PI Financial Suggests a ‘Sell’
Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.
Joe Biden Won’t Legalize Cannabis—Why?
Although Joe Biden supported medical cannabis in his previous presidential campaigns, he has always opposed full-scale legalization.
Canada’s Cannabis Act C-45 Makes Progress in the Senate
On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.
Marijuana in Texas: Five Things You Should Know
Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.
Price Target Update for Canopy Growth in January
Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.
Why Canopy Growth Is Partnering with Drake
The Canadian Press reported that Canopy Growth is partnering with rapper Drake to launch a new cannabis venture, the More Life Growth Company.
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Key Takeaways on the SAFE Banking Act Hearing
On Tuesday, the US Senate held a hearing on the SAFE (Secure and Fair Enforcement) Banking Act. On March 26, the House Committee passed the act. The act will need to pass the Senate before it is sent to the US president. If passed, the act would greatly help US cannabis businesses. What is the […]
Which Cannabis Stocks Have Lost More than 40% in 2019?
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
Cannabis Legalization: Is It Time for the US to Act?
Cannabis legalization has America’s attention. A Gallup survey has shown that two-thirds of Americans want cannabis legalized now.
Cannabis 2.0 Legalization: Canada Is Ready
Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]
How Cannabis Companies Are Rushing to Expand Operations
In anticipation of recreational cannabis’s legalization at the federal level in Canada, provinces have been doing their best to prepare.
Why Canopy Growth Is a ‘Buy’ before Its Earnings
Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?
Cannabis Beverages: Why Canadians Can’t Wait
Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.
Why Does Jim Cramer Prefer CGC versus CRON?
Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.
No Cannabis Edibles in Three Provinces for Christmas
After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.
Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market
Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.
How Cannabis Stocks Performed Last Week
Strong sentiment in the cannabis sector pushed cannabis ETFs and stocks into positive territory last week.
Will Aurora Cannabis Turn the Corner in 2020?
Despite being prepared after Canada legalized recreational cannabis in 2018, Aurora Cannabis struggled to hit its revenue numbers.
Marijuana Campaigns Continue in Nebraska and Montana
Nebraska needs to collect 130,000 valid signatures from registered voters by July 8 to qualify recreational marijuana legalization for the November 2020 ballot.
What Analysts Recommend for Cannabis Stocks in March
Most of the major cannabis stocks are in the red on a year-to-date basis.
Why Cannabis Stocks Are on the Rise
The reason cannabis stocks are rising could be because October 17 is approaching.
Was CGC a Big Mistake for Constellation Brands?
Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.
National Access Cannabis to Get Cannabis from CannaRoyalty
Last week, National Access Cannabis signed a binding term sheet with CannaRoyalty (CRZ) to carry the latter’s products in its stores across Canada.
Aphria Reports Quarterly Loss, PI Financial Raises Price Target
Aphria (APH) (APHQF) reported its fiscal 4Q 2018 earnings on August 1. It more than doubled its sales but had a net quarterly loss.
Why Aurora Cannabis Wants to Grow Cannabis Outdoors
Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites.
Could Certain Marijuana Strains Help Fight COVID-19?
The cannabis industry is doing its own research amid COVID-19. Researchers discovered that marijuana might have properties to fight the coronavirus.
How Aurora Cannabis’s Valuations Compare to Its Peers’
On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.
Is Aurora Cannabis Ready for Cannabis 3.0?
Aurora Cannabis (ACB) is ready to launch its new products for Cannabis 2.0. But is the company ready for the next phase? Let’s find out.
Cannabis Legalization: The World Waits for the US
Cannabis legalization is spreading its roots globally. Considering that other countries are legalizing marijuana, will the US follow suit?
What’s Canopy Growth Strategy for Growth?
Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
Arizona’s Marijuana Campaign Qualifies for November Ballot
Marijuana campaigns in most US states faced challenges gathering enough signatures amid the pandemic. However, Arizona got plenty of signatures.
Canopy Growth Completes EBBU Acquisition
Canopy Growth (WEED) (CGC) announced yesterday that it completed the previously announced acquisition of EBBU.
Marijuana Legalization: What’s Happening in Utah?
Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.
Aurora Cannabis: Is This the Right Time to Invest?
Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?
Illinois’ Cannabis Sales Soared in June: Which Stocks Will Benefit?
Cannabis sales have been soaring in all of the US states that classified it as an “essential item” amid the pandemic. Illinois has seen tremendous growth.
Tilray’s Q2 Earnings Are Out: Did It Impress?
In its Q2 earnings report today, Tilray reported a 371% YoY revenue increase to $45.9 million. Tilray beat analysts’ estimate of $41.1 million in revenue.
Has Irwin Simon Really Turned Aphria Around?
Aphria (APHA) has impressed investors with its earnings results this year. Overall, the cannabis industry has struggled due to various headwinds.
Aurora Cannabis: Target Price and Valuation Update
So far, July has been rough for Aurora Cannabis (ACB). The stock has been trending lower ever since the beginning of the month. As of Thursday, the stock has fallen about 17%. However, the stock has delivered a positive return this year. Aurora Cannabis has delivered a positive return of 30% YTD (year-to-date). When we […]
Do Republicans Want to Join the Cannabis Action?
Republicans have been conservative about cannabis. However, cannabis legalization is a popular discussion topic among Democrats.
Will Marijuana Stocks Continue to Surge in June?
May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.
Aphria: Analysts’ Target Price and Ratings
While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.